We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$536M
Cap. Flow %
9.53%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 34.82%
2 Healthcare 28.77%
3 Real Estate 5.15%
4 Financials 4.39%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OFIX icon
276
Orthofix Medical
OFIX
$432M
$1.39M 0.02%
108,032
+40,000
+59% +$720K
ADT icon
277
ADT
ADT
$5.59B
$1.38M 0.02%
229,607
– –
AUTL
278
Autolus Therapeutics
AUTL
$532M
$1.37M 0.02%
585,919
+55,000
+10% +$157K
PTON icon
279
PUT
Peloton Interactive
PTON
$2.38B
$1.36M 0.02%
1,037,500
+737,500
+246% +$5.25M
GDX icon
280
VanEck Gold Miners ETF
GDX
$25.6B
$1.35M 0.02%
+50,000
New +$1.47M
CCJ icon
281
Cameco
CCJ
$40.8B
$1.33M 0.02%
33,500
-5,800
-15% -$205K
VRDN icon
282
Viridian Therapeutics
VRDN
$2.55B
$1.3M 0.02%
84,836
+10,000
+13% +$191K
ANNX icon
283
Annexon
ANNX
$918M
$1.3M 0.02%
549,246
+123,690
+29% +$374K
SAVE
284
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
$1.28M 0.02%
450,000
+200,000
+80% +$3.4M
LCID icon
285
PUT
Lucid Motors
LCID
$2.75B
$1.28M 0.02%
75,000
+5,000
+7% +$324K
VSTM icon
286
Verastem
VSTM
$519M
$1.27M 0.02%
155,904
+5,000
+3% +$48K
TRIS
287
DELISTED
Tristar Acquisition I Corp.
TRIS
$1.25M 0.02%
116,910
– –
RIGL icon
288
Rigel Pharmaceuticals
RIGL
$733M
$1.24M 0.02%
115,177
+12,500
+12% +$150K
JAQC
289
DELISTED
Jupiter Acquisition Corporation Common stock
JAQC
$1.24M 0.02%
120,173
– –
RLAY icon
290
Relay Therapeutics
RLAY
$4.3B
$1.23M 0.02%
146,846
+50,461
+52% +$543K
NVNO
291
enVVeno Medical
NVNO
$6.78M
$1.22M 0.02%
6,466
+1,128
+21% +$188K
PHAT icon
292
Phathom Pharmaceuticals
PHAT
$679M
$1.22M 0.02%
117,280
-23,000
-16% -$315K
DNLI icon
293
Denali Therapeutics
DNLI
$3.92B
$1.22M 0.02%
58,952
+10,000
+20% +$254K
AXGN icon
294
Axogen
AXGN
$2.38B
$1.2M 0.02%
239,196
-37,387
-14% -$259K
KPTI icon
295
Karyopharm Therapeutics
KPTI
$44.2M
$1.17M 0.02%
58,447
+18,000
+45% +$404K
IFRX icon
296
InflaRx
IFRX
$253M
$1.16M 0.02%
390,000
+85,000
+28% +$324K
IWM icon
297
PUT
iShares Russell 2000 ETF
IWM
$82.1B
$1.15M 0.02%
350,000
+10,000
+3% +$1.88M
PRCT icon
298
Procept Biorobotics
PRCT
$1.15B
$1.15M 0.02%
35,116
-16,000
-31% -$545K
UBER icon
299
Uber
UBER
$144B
$1.15M 0.02%
+25,000
New +$1.14M
STRO icon
300
Sutro Biopharma
STRO
$400M
$1.15M 0.02%
+33,000
New +$1.44M
10 11
12
13 14

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.